HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel missense mutations affecting the structure of the conserved fibrinogen Bβ C-terminal domain cause congenital hypofibrinogenemia.

Abstract
This study describes the identification of two new mutations of the fibrinogen beta-chain in patients with inherited fibrinogen deficiency. Modelling of the impact of the mutations predict that these single amino acid substitutions are sufficient to abolish secretion of the mutant chains into the circulation, resulting in low fibrinogen levels in the patients. In addition, whole exome sequencing identified genetic modifiers for both patients which could contribute to the patients' global hemostatic function. Our results yield clinically relevant information for the personalised management of patients and eventually precision medicine for fibrinogen disorders.
AuthorsRaquel Bártolo, Maxime Arbez, Rui Vilar, Timea Szanto, Elina Lehtinen, Nathalie Trillot, Antoine Rauch, Alessandro Casini, Marguerite Neerman-Arbez
JournalThrombosis research (Thromb Res) Vol. 206 Pg. 5-8 (10 2021) ISSN: 1879-2472 [Electronic] United States
PMID34352655 (Publication Type: Letter)
CopyrightCopyright © 2021 Elsevier Ltd. All rights reserved.
Chemical References
  • BBeta fibrinogen
  • Fibrinogen
Topics
  • Afibrinogenemia (genetics)
  • Amino Acid Substitution
  • Fibrinogen (genetics)
  • Humans
  • Mutation, Missense

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: